Healthcare & Life Sciences Drug Pricing Digest - April 2025

The Latham drug pricing and market access team invites you to read this digest of recent developments on healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....
By: Latham & Watkins LLP

Array